期刊文献+

吡仑帕奈治疗儿童难治性癫痫的研究进展 被引量:5

Advances of adjunctive Perampanel in children with refractory epilepsy
下载PDF
导出
摘要 吡仑帕奈是第三代新型抗癫痫药,自其上市,已经在许多国家广泛用于治疗各种儿童癫痫,并取得较好疗效。本文综述了吡仑帕奈在儿童难治性癫痫治疗方面的临床疗效、不良反应、认知功能影响等,有助于临床医生更全面地了解吡仑帕奈在儿童癫痫治疗方面的临床特点,尽可能大地在控制发作和降低不良反应间取得平衡,以更好地治疗癫痫患儿。 Perampanel, an antiepileptic drug, belongs to the third generation. Since it went on the market, it has been widely used to treat various types of pediatric epilepsy and proved to be effective in many countries. This paper reviews the clinical efficacy, adverse reactions and cognitive effects of perampanel in the treatment of refractory epilepsy among pediatric patients. We hope to help pediatricians to understand more about perampanel, so as to maximize the therapeutic effects and minimize the side effects of the drug. Further, manage the refractory epilepsy better in children.
作者 褚思嘉 汤继宏 CHU Si-jia;TANG Ji-hong(Department of Neurology,Children’s Hospital of Soochow University,Soochow 215025,China)
出处 《临床神经病学杂志》 CAS 2021年第5期390-393,共4页 Journal of Clinical Neurology
基金 苏州市科技计划(民生科技)项目(SS201866) 江苏省卫生健康委科技课题面上项目(H2018010)。
关键词 吡仑帕奈 难治性癫痫 儿童 疗效 不良反应 perampanel refractory epilepsy children effectiveness adverse reactions
  • 相关文献

参考文献4

二级参考文献29

共引文献27

同被引文献37

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部